Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Apellis, Akeso, Astrazeneca, Biogen, Clearside, CSL Behring, GSK, Iaso, Impact, Innovent, Junshi, Kalvista, Telix, Vyluma, Zai Lab.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Astrazeneca, Axsome, Bavarian Nordic, BMS, Celltrion, Daiichi Sankyo, Merck, Pfizer, Sanofi, Vertex, Viiv, Zai Lab.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Bioretec, Essilorluxottica, Roche.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Amgen, Comanche, Dilafor, Karolinska, Ironwood, March.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Emmaus, Iaso, Novo Nordisk, Scholar Rock, Vicore, Vyluma, Zhaoke.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Curonix, Life Spine, Orthopreserve, Synthetic MR.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: GE Healthcare, Roche.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Apellis, Astrazeneca, Beacon, CSL, Daiichi, GSK, March Biosciences, Saol, Seed.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Akeso, Alvotech, Biogen, Cartesian, Corstasis, Eisai, Immunitybio, Invivyd, Merck, Teva, Vanda.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: AI Optics, Beckman Coulter, Claritas, Fresenius Kabi, Instylla, Modella.